ASXL2 and leukemia: Given the alterations of enhancers in human AML1-ETO cells with ASXL2 loss, we next examined the chromatin state of AE9a leukemias with or without Asxl2 expression by transposase-accessible chromatin sequencing (ATAC-Seq).